ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Remifentanil Fresenius:Fresenius Kabi (Schweiz) AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
N01AH06 - RemifentanilATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N01 - Anesthetics
 

No DDDs have been established in this group because the doses used vary substantially.

N01A - Anesthetics, General

This group comprises agents which produce general anesthesia, surgical analgesia or neuroleptanalgesia. See also M03A - Peripherally acting muscle relaxants.
Benzodiazepine derivatives are classified in N05BA or N05CD.

N01AH - Opioid Anesthetics

Opioid anesthetics in combination with other anesthetics are classified in this group at separate 5th levels using the corresponding 50-series.
Transdermal, nasal and sublingual formulations of fentanyl are classified in N02AB.
Fentanyl in combination with bupivacaine for e.g. postoperative pain is classified in N01AH51 - fentanyl, combinations.

N01AH06 - Remifentanil
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home